Umbilical Cord-Derived Mesenchymal Stem Cells (Shanghai Life Science & Technology)

N/A

Report date: 2025/01/26 15:57:39

Base Information

Drug NameUmbilical Cord-Derived Mesenchymal Stem Cells (Shanghai Life Science & Technology)
Drug Alias Nameumbilical cord-derived mesenchymal stem cells (Shanghai Life Science & Technology)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Life Science & Technology
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Life Science & Technology
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A